Validating the RISE UP score for predicting prognosis in patients with COVID-19 in the emergency department: a

Paul Mel van Dam1, Noortje Zelis2,3,4, Patricia Stassen2,5

  • 1Department of Internal Medicine, Division of General Internal Medicine, Section Acute Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands paul.van.dam@mumc.nl.

BMJ Open
|February 7, 2021
PubMed

Insights

The Risk Stratification in the Emergency Department in Acutely ill Older Patients (RISE UP) score accurately predicts 30-day mortality in COVID-19 patients. This tool helps identify high-risk individuals for better healthcare resource allocation.

Area of Science:

  • Emergency Medicine
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 poses a significant burden on healthcare systems, necessitating accurate prognostic tools.
  • The Risk Stratification in the Emergency Department in Acutely ill Older Patients (RISE UP) score demonstrates strong predictive value for mortality in older emergency department (ED) patients.
  • The utility of the RISE UP score for predicting outcomes in COVID-19 patients requires investigation.

Purpose of the Study:

  • To evaluate the discriminatory value of the RISE UP score for 30-day mortality in emergency department (ED) patients diagnosed with COVID-19.
  • To assess the RISE UP score's ability to predict a composite outcome of 30-day mortality and intensive care unit (ICU) admission.

Main Methods:

  • Retrospective analysis of 642 adult COVID-19 patients admitted to two EDs between March and May 2020.
  • Inclusion criteria included symptoms suggestive of COVID-19 with positive PCR or high suspicion based on chest CT scan.
  • Primary outcome was 30-day mortality; secondary outcome was a composite of 30-day mortality and ICU admission.

Main Results:

  • The RISE UP score demonstrated good discriminatory value for 30-day mortality (AUC 0.77) and the composite outcome (AUC 0.72).
  • Among patients with RISE UP scores below 10%, there were no deaths and only six ICU admissions.
  • Patients with RISE UP scores above 30% experienced high rates of adverse outcomes, including 46.6% mortality and 19.0% ICU admissions.

Conclusions:

  • The RISE UP score is a validated prognostic model for adverse outcomes in COVID-19 patients presenting to the ED.
  • This score can effectively identify patients at high risk for short-term adverse events.
  • The RISE UP score may aid in clinical decision-making and the strategic allocation of healthcare resources during the pandemic.
Abstract

Related Concept Videos